Cargando…

Bioinformatics analysis of the clinical value and potential mechanisms of AHNAK2 in papillary thyroid carcinoma

Background: AHNAK2 has been recently reported as a biomarker in many cancers. However, a systematic investigation of AHNAK2 in papillary thyroid carcinoma (PTC) has not been conducted. Results: AHNAK2 is overexpressed in PTC tissues and could be an independent prognostic factor. AHNAK2 expression wa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xie, Zhenyu, Lun, Yu, Li, Xin, He, Yuzhen, Wu, Song, Wang, Shiyue, Sun, Jianjian, He, Yuchen, Zhang, Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7585101/ https://www.ncbi.nlm.nih.gov/pubmed/32966238 http://dx.doi.org/10.18632/aging.103645

Ejemplares similares

Analysis of the Prognostic Value and Potential Molecular Mechanisms of TREM-1 Overexpression in Papillary Thyroid Cancer via Bioinformatics Methods
por: Xie, Zhenyu, et al.
Publicado: (2021)

Immune Cell Confrontation in the Papillary Thyroid Carcinoma Microenvironment
por: Xie, Zhenyu, et al.
Publicado: (2020)

Analysis of the expression and potential molecular mechanism of interleukin-1 receptor antagonist (IL1RN) in papillary thyroid cancer via bioinformatics methods
por: Xie, Zhenyu, et al.
Publicado: (2020)

Bioinformatics analysis to screen key genes in papillary thyroid carcinoma
por: Liu, Yuanhu, et al.
Publicado: (2020)

The Obscure Potential of AHNAK2
por: Zardab, Mohamed, et al.
Publicado: (2022)

Identification of potential therapeutic targets for papillary thyroid carcinoma by bioinformatics analysis
por: ZHAO, MING, et al.
Publicado: (2016)

AHNAK Contributes to Hepatocellular Carcinoma Growth by Interacting with IGF-1R
por: Li, Kang, et al.
Publicado: (2022)

AHNAK and Inflammatory Markers Predict Poor Survival in Laryngeal Carcinoma
por: Dumitru, Claudia A., et al.
Publicado: (2013)

AHNAKs roles in physiology and malignant tumors
por: Zhang, Shusen, et al.
Publicado: (2023)

AHNAK2 is a biomarker and a potential therapeutic target of adenocarcinomas: AHNAK2 is a biomarker for adenocarcinomas
por: Xu, Meng, et al.
Publicado: (2022)

Identification and Validation of Core Genes Involved in the Development of Papillary Thyroid Carcinoma via Bioinformatics Analysis
por: Li, Xiaoyan, et al.
Publicado: (2019)

Special role of JUN in papillary thyroid carcinoma based on bioinformatics analysis
por: Chen, Wenzheng, et al.
Publicado: (2017)

Identification and analysis of genes associated with papillary thyroid carcinoma by bioinformatics methods
por: Zhang, Shulong, et al.
Publicado: (2019)

Identification of key genes of papillary thyroid carcinoma by integrated bioinformatics analysis
por: Xue, Gang, et al.
Publicado: (2020)

Integrated bioinformatics analysis and screening of hub genes in papillary thyroid carcinoma
por: Fan, Rong, et al.
Publicado: (2021)

Prognostic value of the BRAF V600E mutation in papillary thyroid carcinoma
por: HE, GUOPING, et al.
Publicado: (2014)

AHNAK as a Prognosis Factor Suppresses the Tumor Progression in Glioma
por: Zhao, Zijin, et al.
Publicado: (2017)

Bioinformatics analysis of the prognostic and clinical value of senescence-related gene signature in papillary thyroid cancer
por: Wen, Tingting, et al.
Publicado: (2023)

Identifying and analyzing the key genes shared by papillary thyroid carcinoma and Hashimoto’s thyroiditis using bioinformatics methods
por: Liu, Ting-ting, et al.
Publicado: (2023)

Identification of a Four-Gene Signature for Determining the Prognosis of Papillary Thyroid Carcinoma by Integrated Bioinformatics Analysis
por: Luo, Yuting, et al.
Publicado: (2022)

Experimental study on changes in metabolic mechanism of papillary thyroid carcinoma complicated with Hashimoto’s thyroiditis
por: Sun, Danyang, et al.
Publicado: (2023)

Genetic Alterations in Papillary Thyroid Carcinoma With Hashimoto(’)s Thyroiditis： ANK3, an Indolent Maintainer of Papillary Thyroid Carcinoma
por: Zeng, Chao, et al.
Publicado: (2022)

Identification of key candidate genes and pathways in follicular variant papillary thyroid carcinoma by integrated bioinformatical analysis
por: Jing, Lanyu, et al.
Publicado: (2020)

Papillary Thyroid Carcinoma: A thorough Bioinformatic Analysis of Gene Expression and Clinical Data
por: Petrini, Iván, et al.
Publicado: (2023)

Uncovering the pathogenesis of obesity complicated with papillary thyroid carcinoma via bioinformatics and experimental validation
por: Yuan, Kaisheng, et al.
Publicado: (2023)

Changes in Treg numbers and activity in papillary thyroid carcinoma with and without Hashimoto’s thyroiditis
por: Zhao, Na, et al.
Publicado: (2020)

Identification of a Six Gene Prognosis Signature for Papillary Thyroid Cancer Using Multi-Omics Methods and Bioinformatics Analysis
por: Ren, He, et al.
Publicado: (2021)

Analysis of the Clinical Value of Delphian Lymph Node Metastasis in Papillary Thyroid Carcinoma
por: Zuo, Qiumei, et al.
Publicado: (2022)

The prognostic value of the lymphocyte-to-monocyte ratio for high-risk papillary thyroid carcinoma
por: Song, Linlin, et al.
Publicado: (2019)

Assessing Diagnostic Value of Combining Ultrasound and MRI in Extrathyroidal Extension of Papillary Thyroid Carcinoma
por: Hu, Shudong, et al.
Publicado: (2022)

AHNAK2 is a potential prognostic biomarker in patients with PDAC
por: Lu, Di, et al.
Publicado: (2017)

Identifying hub genes of papillary thyroid carcinoma in the TCGA and GEO database using bioinformatics analysis
por: Wan, Ying, et al.
Publicado: (2020)

Overexpression of RNF38 facilitates TGF-β signaling by Ubiquitinating and degrading AHNAK in hepatocellular carcinoma
por: Peng, Rui, et al.
Publicado: (2019)

Value of Contrast-Enhanced Ultrasound in Partially Cystic Papillary Thyroid Carcinomas
por: Fang, Fengkai, et al.
Publicado: (2021)

Thyroid Metastasis from Breast Carcinoma Accompanied by Papillary Thyroid Carcinoma
por: Yang, Song-I, et al.
Publicado: (2014)

Diagnostic and prognostic value of STAP1 and AHNAK methylation in peripheral blood immune cells for HBV-related hepatopathy
por: Sun, Libo, et al.
Publicado: (2023)

Synchronous primary hyperparathyroidism, follicular thyroid carcinoma, and papillary thyroid carcinoma
por: Dai, Dong-Jun, et al.
Publicado: (2019)

Synchronous papillary thyroid carcinoma and breast ductal carcinoma
por: Kong, Heng, et al.
Publicado: (2020)

Papillary Thyroid Carcinoma and Inflammation
por: Fugazzola, Laura, et al.
Publicado: (2011)

BRAF in Papillary Thyroid Carcinoma
por: Lanzilotta, Salvatore Giovanni, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_8lkpob96e5ag4bcp5v26d9jbch